02196.HK
Shanghai Fosun Pharmaceutical (Group) Co., Ltd.
HKSE · Healthcare · Drug Manufacturers - Specialty & Generic · CN
HKD 17.32
+0.99%Forward multiples
Based on analyst estimates
- P/E forward
- 21.95x
- P/E 2026E
- 9.79x
- P/E 2027E
- 8.67x
- P/E 2028E
- 7.55x
- P/S forward
- 2.13x
Trailing multiples
Trailing twelve months
- P/E TTM
- 7.80x
- PEG TTM
- —
- Price / book
- 0.80x
- Price / sales
- 0.63x
- Price / cash flow
- 7.10x
Enterprise value
- Enterprise value
- HKD 89.9B
- EV / sales
- 1.25x
- EV / EBITDA
- 10.38x
- EV / EBIT
- 15.01x
- Market cap
- HKD 45.7B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026